EU MDR Vigilance & Trend Reporting: A Deep Dive into CAPA and FSCA Decisions

This episode explores the critical operational hotspots in medical device vigilance under regulations like the EU MDR. We examine the pressures for faster, higher-quality incident investigations, the complexities of making accurate MDR reportability decisions, and the nuances of establishing effective trend reporting thresholds. Discover how these vigilance activities are directly linked to your CAPA system, FSCA decisions, and the overall credibility of your Post-Market Surveillance (PMS) system during Notified Body audits. Key Questions: - How can you speed up incident investigations without sacrificing quality? - What are the key factors in making an accurate MDR reportability decision? - How do you establish meaningful thresholds for trend reporting? - What is the direct link between your vigilance system and your CAPA process? - How do Field Safety Corrective Actions originate from post-market vigilance data? - What will a Notified Body look for when auditing your incident-to-CAPA traceability? - Why is under-reporting incidents just as risky as over-reporting? Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies, streamlining global market access. Our experts help you build robust post-market surveillance and vigilance systems that meet stringent standards like the EU MDR. We develop efficient pathways for compliance, using advanced AI to manage technical dossiers and monitor regulatory changes. From initial strategy and registration to post-market surveillance and quality assurance, Pure Global ensures your products remain compliant and safe. Let us be your local representative and navigate complex vigilance requirements. Visit https://pureglobal.com/, email [email protected], or explore our FREE AI tools and database at https://pureglobal.ai.